Ajanta Pharmaceuticals Q3 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
3,001.8
41.50 (1.40%)
41.50 (1.40%)Volume8.27 K
Updated: Mon 25 Nov, 2024 | 15:56:58
NSE
2,996.736.65 (1.24%)
36.65 (1.24%)Volume1.35 L
Updated: Mon 25 Nov, 2024 | 15:44:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Ajanta Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,105.15 | 1,028.44 | -% | 971.77 | -% |
| Selling/ General/ Admin Expenses Total | 231.35 | 222.27 | -% | 192.42 | -% |
| Depreciation/ Amortization | 34.26 | 33.71 | -% | 33.30 | -% |
| Other Operating Expenses Total | 257.98 | 259.39 | -% | 303.48 | -% |
| Total Operating Expense | 817.76 | 771.49 | -% | 798.53 | -% |
| Operating Income | 287.39 | 256.95 | -% | 173.24 | -% |
| Net Income Before Taxes | 290.91 | 275.94 | -% | 168.34 | -% |
| Net Income | 210.03 | 195.30 | -% | 134.51 | -% |
| Diluted Normalized EPS | 16.67 | 15.50 | -% | 10.50 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST